NASDAQ: CRBU
Caribou Biosciences Inc Stock Ownership - Who owns Caribou Biosciences?

Insider buying vs selling

Have Caribou Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rachel E. HaurwitzPresident and CEO2025-03-1420,000$1.02
$20.40kBuy
Steven KannerChief Scientific Officer2025-02-213,564$1.35
$4.81kSell
Ruhi Ahmad KhanChief Business Officer2025-02-213,564$1.35
$4.81kSell
Barbara G. McClungChief Legal Officer2025-02-213,564$1.35
$4.81kSell

1 of 1

CRBU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBU insiders and whales buy or sell their stock.

CRBU Shareholders

What type of owners hold Caribou Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pfizer Inc5.02%4,690,431$6.85MInstitution
Vanguard Group Inc4.52%4,226,926$6.17MInstitution
Rachel E. Haurwitz3.92%3,664,845$5.35MInsider
Fmr LLC3.56%3,323,284$4.85MInsider
Millennium Management LLC3.44%3,216,535$4.70MInstitution
Kynam Capital Management LP3.28%3,067,774$4.48MInstitution
Blackrock Inc1.56%1,459,320$2.13MInstitution
Aberdeen Group PLC1.49%1,388,905$2.03MInstitution
Pfm Health Sciences LP1.45%1,358,831$1.98MInstitution
Two Sigma Advisers LP1.31%1,227,400$1.79MInstitution

1 of 3

CRBU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBU39.75%8.81%Net Buying
NBY0.09%99.91%Net Buying
PRLD43.21%52.21%Net Buying
BDTX65.77%34.23%Net SellingNet Buying
CNTB2.90%0.00%

Caribou Biosciences Stock Ownership FAQ

Who owns Caribou Biosciences?

Caribou Biosciences (NASDAQ: CRBU) is owned by 39.75% institutional shareholders, 8.81% Caribou Biosciences insiders, and 51.44% retail investors. Rachel E. Haurwitz is the largest individual Caribou Biosciences shareholder, owning 3.66M shares representing 3.92% of the company. Rachel E. Haurwitz's Caribou Biosciences shares are currently valued at $5.72M.

If you're new to stock investing, here's how to buy Caribou Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.